BUZZ-Australia's AdAlta soars to over a month high on cancer treatment partnership
Reuters
Jan 02
BUZZ-Australia's AdAlta soars to over a month high on cancer treatment partnership
** Shares of AdAlta 1AD.AX rise as much as 33.4% to A$0.004, its biggest intraday pct gain in over a month
** Stock touches its highest level since November 24
** Biotech firm says co and unit, AdCella have signed partnership agreement with Shanghai Cell Therapy Group to co-develop Chinese cell tech co's cancer treatment, BZDS1901, to markets outside China
** BZDS1901 targets specific proteins, treating aggressive and fatal cancers such as mesothelioma
** Stock fell 77.7% in 2025
(Reporting by Aamir Sheik Khalid in Bengaluru)
((Aamir.SheikKhalid@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.